NCT06997770

Brief Summary

According to 2017 World Workshop of Periodontology , the level of high sensitivity C reactive protein has been assumed to increase according to the grade of periodontitis, however, specific evidence regarding this is lacking at present. Hence, measuring high sensitivity C reactive protein in serum and oral rinse samples in systemically healthy individuals with periodontitis could be potentially useful in gaining insight on the systemic burden of periodontal disease.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P50-P75 for all trials

Timeline
3mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Jun 2025Aug 2026

First Submitted

Initial submission to the registry

May 12, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 30, 2025

Completed
26 days until next milestone

Study Start

First participant enrolled

June 25, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 25, 2026

Last Updated

May 30, 2025

Status Verified

May 1, 2025

Enrollment Period

1 year

First QC Date

May 12, 2025

Last Update Submit

May 22, 2025

Conditions

Keywords

periodontits

Outcome Measures

Primary Outcomes (1)

  • Evaluation of hscrp level in oral rinse samples and serum in 3 groups of systemically healthy individuals

    Evaluation of hsCRP level in oral rinse samples and serum in 3 groups of systemically healthy individuals (periodontally healthy, stage III and stage IV grade B generalized periodontitis, stage III and stage IV grade C generalized periodontitis)

    12-14 months

Secondary Outcomes (2)

  • Correlation of Probing pocket depth (PPD)and Clinical attachment level (CAL) with level of hsCRP in oral rinse and serum samples.

    12-14 months

  • Correlation of Bleeding on probing (BOP%)

    12-14 months

Study Arms (3)

generalized periodontitis STAGE III/IV , Grade B

29 systemically healthy individuals With stage III /IV and grade B

generalized periodontitis STAGE III/IV , Grade C

29 systemically healthy individuals With stage III /IV and grade C

Periodontally healthy individuals

29 systemically and periodontally healthy individuals

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

1. Group 1: comprising of periodontally healthy individuals. 2. Group 2: comprising of individuals, diagnosed with stage III and stage IV grade B periodontitis (according to WWP 2017 classification periodontal disease ) 3. Group 3: comprising of participants, diagnosed with stage III and IV grade C periodontitis,

You may qualify if:

  • Patients in the age group of (18-50 years)
  • Presence of ≥ 20 natural teeth
  • Ability and willingness to give written informed consent
  • Patients belonging to 3 groups -periodontally healthy, stage III and stage IV grade B periodontitis, and stage III and stage IV grade C periodontitis .

You may not qualify if:

  • Patients with chronic inflammatory disease such as nephrotic syndrome, chronic renal failure, significant cardiovascular disease, established type 1 or type 2 diabetes mellitus, or active cancer within the past 5 years
  • Smokers and alcoholics
  • Pregnant females
  • Presence of xerostomia
  • Patients undergoing radiotherapy
  • Having received professional periodontal treatment within the previous 6 months
  • Having received antibiotic medication 3 months prior to study
  • Periapical pathology or other oral inflammatory conditions
  • Cognitive disability (interfering with ability to give sample)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PGIDS

Rohtak, Haryana, 124001, India

Location

Study Officials

  • Dr Aditi Sangwan, MDS

    PGIDS ,ROHTAK

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Neha Sahjlan, MDS

CONTACT

Dr Sanjay Tewari, MDS

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 12, 2025

First Posted

May 30, 2025

Study Start

June 25, 2025

Primary Completion (Estimated)

June 25, 2026

Study Completion (Estimated)

August 25, 2026

Last Updated

May 30, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations